Partnering opportunities

In-vivo companies looking to collaborate

Business and academia from UK and around the world looking to partner to co-develop in-vivo technology. We can connect you.

We help ambitious, post-start up businesses, to

  • Move into new markets
  • Access funding
  • Use our networks
  • Innovate to grow
  • Find trusted partners
Innovate UK
HM Government
European Commission

Start new search
Refine

48 total opportunities

Filter your results

I’m looking for a partner...
Country of origin

{[{ data.total | number }]} opportunities

48 opportunities

Get updates to this list

The search results below each have a summary which you may find useful in determining if the opportunity is what you’re looking for.

{[{ row.title }]}

{[{ row.summary }]}

Country of origin {[{ row.country }]}

Benchtop small sized systems for affordable in-vivo molecular imaging

A Greek SME with significant research and professional experience in the field of biomedical engineering and mainly in the emerging molecular imaging technology has developed two... more

Greece

Micro fluidic system for simulating in vivo-equivalent cell barriers

The German university is specialised in micro fluidic systems and carries out applied research in biological barrier systems. In vivo... more

Germany

Technology to transfect DNA into cells in vivo without viral vectors

The aim of the method / product is to transfect plasmid DNA into cells in vivo and especially in muscle cells without the use of viral vectors and without... more

Belgium

Photoacoustic in vivo imaging with near infrared-dye doped nanoparticles to further develop by a reasearch/technical agreement

ultrasound technology. Usually, organic dyes and gold nanoparticles (NPs) can be used as a contrast agent for PA imaging. Organic dyes are commonly sensitive to photobleaching and decompose fast in vivo,... more

Germany

An established Slovak research institute has developed a unique system for in vivo isolation of circulating tumour cells from peripheral blood and is looking for licensees or investors

the Slovak research institute in cooperation with Slovak university has developed a unique system for in vivo isolation of circulating tumour cells... more

Slovakia

High-end systems for small-sized animal imaging.

. These services include characterization of biomolecules and nanoparticles, functionalization, radiolabelling, ex vivo biodistribution and in vivo... more

Greece

Expertise for a high quality design of preclinical studies

needs to prove the efficacy of new drugs in vivo for the treatment of neurological or psychiatric disorders or biocompatibility of biomedical devices. The company has longstanding,... more

Italy

UK-based SME offers novel small molecule for treatment of cancer

Wnt signalling is implicated, such as stonach, liver and pancreatic cancer. Testing on this molecule shows that it displays anti-proliferative activity in pre-clinical in vivo... more

United Kingdom

Unique Approach for the Study of Immune System Funcionality

Within immune system functionality studies, Enzyme-Linked Immunospot (ELISpot), detects the Effector T cells cytokines secretion with an in vitro system that closely resembles the in... more

Italy

French Technology Transfer Office offers new solid cancer treatment targeting cancer stem-cells

inhibites a cell surface receptor of the above-mentioned specific signaling pathway in the CSCs, has been identified in glioblastoma. The proof of concept of such inhibition using... more

France

Surface modifications and coating technologies for the medical industry.

surface modifications, but also in product development. With years of experience in bringing medical products to market, they can assist in in... more

Netherlands

Inventor of a novel semi-solid and liquid phytopreparations with the strong antibacterial effects is looking for a commercial agreement with technical assistance or license agreement.

. The phytopreparations can be used in human and veterinary medicine. In vivo anti-inflammatory effect of the preparation was tested in... more

Serbia

Printed medical solution

. Experimental models (in vivo experiments), performed and coordinated by the startup’s experienced staff, are used for investigating the tissue repair and tissue regeneration properties... more

Italy

A multifunctional linker for chimeric antigen receptor T-cells

. For a large number of constructs, the hinge region consists of the CH2CH3 domain of a human IgG antibody. This can bind to Fcg-receptors on macrophages and other cells. The result is cross-activation and activation-induced cell death more

Germany

A French Technology Transfer Office offers a novel anti-cancer chemical compound

properties validated in vitro and in vivo. It is a class of chemical agents targeting tubulin polymerization with a high hydrophilic structure and... more

France

Improved skin model based on lanoline synthetic membranes

overcome ethical and economic issues related to in vivo human studies. However, the in vitro skin models are expensive, sensitive to storage and show... more

Spain

Heparin albumin containing adsorbents for hemoperfusion

1.5 0.2( n=19) is significantly higher than those of uncoated charcoal 1.10.2 (n=31), idem for anti-n-DNA AT 1.60.18 (n=6) and 1.0 0.18(n=6). Albumin-heparin containing hemoadsorbents will be developed and tested in... more

Ukraine

A French Technology Transfer Office offers a new compound for the treatment of diabetes

administration of non-toxic doses of this compound in preclinical models of diabetes is associated with reduced body weight and adiposity, improved glucose tolerance and enhanced glucose-stimulated insulin secretion... more

France

Targeted anti-cancer drug delivery system.

efficiency of anti-cancer drugs which leads to more efficient and less costly treatments. Successful functioning of the system has been demonstrated both in vitro on various cell cultures and in... more

Slovenia

Innovative biological biomaterial for surgical applications

. - Developing new products in collaboration with companies interested in regenerative medicine market. The company's business strategy consists in... more

Italy

The right partner not here?

Get in touch and we'll help you post a partnering opportunity

Hash